BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30076843)

  • 21. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.
    Van Laethem JL; Jagodzinski R; Peny MO; Cremer M; Devière J
    Endoscopy; 2001 Mar; 33(3):257-61. PubMed ID: 11293760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm.
    Alvarez Herrero L; van Vilsteren FG; Pouw RE; ten Kate FJ; Visser M; Seldenrijk CA; van Berge Henegouwen MI; Fockens P; Weusten BL; Bergman JJ
    Gastrointest Endosc; 2011 Apr; 73(4):682-90. PubMed ID: 21292262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus: late outcomes from two randomized trials.
    Sie C; Bright T; Schoeman M; Game P; Tam W; Devitt P; Watson D
    Endoscopy; 2013 Nov; 45(11):859-65. PubMed ID: 24019134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete Barrett's excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture.
    Chung A; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; McLeod D; Fanning S; Kariyawasam V; Byth K
    Endoscopy; 2011 Dec; 43(12):1025-32. PubMed ID: 22068701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia.
    Kim MP; Brown KN; Schwartz MR; Blackmon SH
    Innovations (Phila); 2013; 8(1):17-22. PubMed ID: 23571789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic therapy of esophageal premalignancy and early malignancy.
    Nealis TB; Washington K; Keswani RN
    J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
    Raphael KL; Trindade AJ
    World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.
    Bright T; Watson DI; Tam W; Game PA; Ackroyd R; Devitt PG; Schoeman MN
    Dig Dis Sci; 2009 Dec; 54(12):2606-11. PubMed ID: 19101798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus.
    Reddy CA; Tavakkoli A; Chen VL; Korsnes S; Bedi AO; Carrott PW; Chang AC; Lagisetty KH; Kwon RS; Elmunzer BJ; Orringer MB; Piraka C; Prabhu A; Reddy RM; Wamsteker E; Rubenstein JH
    Dig Dis Sci; 2021 May; 66(5):1580-1587. PubMed ID: 32519141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
    Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
    Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
    Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
    Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett's oesophagus: a multicentre randomised controlled trial.
    Pouw RE; Künzli HT; Bisschops R; Sondermeijer CM; Koch AD; Didden P; Gotink AW; Schoon EJ; Curvers WL; Bergman JJGHM; Weusten BLAM
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):566-574. PubMed ID: 29934224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
    Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
    Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma.
    Bahin FF; Jayanna M; Hourigan LF; Lord RV; Whiteman D; Williams SJ; Lee EY; Bourke MJ
    Gastrointest Endosc; 2016 Jan; 83(1):68-77. PubMed ID: 26096759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial.
    Barret M; Pioche M; Terris B; Ponchon T; Cholet F; Zerbib F; Chabrun E; Le Rhun M; Coron E; Giovannini M; Caillol F; Laugier R; Jacques J; Legros R; Boustiere C; Rahmi G; Metivier-Cesbron E; Vanbiervliet G; Bauret P; Escourrou J; Branche J; Jilet L; Abdoul H; Kaddour N; Leblanc S; Bensoussan M; Prat F; Chaussade S
    Gut; 2021 Jun; 70(6):1014-1022. PubMed ID: 33685969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
    Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
    Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett's Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials.
    Wang Y; Ma B; Yang S; Li W; Li P
    Front Oncol; 2022; 12():801940. PubMed ID: 35296005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.